Online citations, reference lists, and bibliographies.
← Back to Search

Particle Size And Surface Charge Affect Particle Uptake By Human Dendritic Cells In An In Vitro Model.

C. Foged, B. Brodin, S. Frokjaer, A. Sundblad
Published 2005 · Medicine, Chemistry, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Current vaccine development includes optimization of antigen delivery to antigen presenting cells, such as dendritic cells (DC). Particulate systems have attracted increasing attention in the development of vaccine delivery systems. In the present study, we investigated DC uptake of model fluorescent polystyrene particles with a broad size range and variable surface properties. Localization of particles was investigated using confocal laser scanning microscopy and uptake was quantified by flow cytometry. Immature DC were generated from mononuclear cells isolated from human blood. The polystyrene particles interacted with the DC throughout the tested diameter range of 0.04-15 microm in a time- and concentration-dependent manner. The optimal particle diameter for fast and efficient acquisition by a substantial percentage of the DC was 0.5 microm and below. The surface of 1 and 0.1 microm polystyrene particles was covalently modified with different polyaminoacids/proteins, yielding particles with varying surface charge. Uptake of 1 microm particles was greatly enhanced when particles displayed a positive surface charge. In general, the present findings establish that particle diameters of 0.5 microm and below were optimal for DC uptake; however uptake of larger particles could be greatly enhanced by rendering the particle surface positive. Whether increased particle uptake is correlated with increased immune responses, remains to be established.
This paper references
10.1023/A:1022271020390
Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages
L. Thiele (2004)
Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
L. Vidard (1996)
10.1046/j.1440-1711.2001.01011.x
Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes
J. Reece (2001)
10.1016/S0168-3659(01)00412-6
Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?
L. Thiele (2001)
10.1084/JEM.182.2.283
The endocytic activity of dendritic cells
R. Steinman (1995)
Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
C. Harding (1994)
10.1016/0142-9612(88)90033-6
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage.
Y. Tabata (1988)
10.1084/JEM.178.2.509
Phagocytosis of antigens by Langerhans cells in vitro
C. Reis e Sousa (1993)
10.1038/32588
Dendritic cells and the control of immunity
J. Banchereau (1998)
10.1016/0022-1759(96)00078-6
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.
G. Schuler (1997)
10.1089/089426801316970240
Evaluation of phagocytic activity in human monocyte-derived dendritic cells.
S. Kiama (2001)
10.1016/J.VACCINE.2003.11.008
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition.
C. Foged (2004)
10.1084/JEM.179.4.1109
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
F. Sallusto (1994)
10.1038/3469
Fully mobilizing host defense: Building better vaccines
S. Raychaudhuri (1998)
10.1084/JEM.182.2.389
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products
F. Sallusto (1995)
10.1073/PNAS.90.11.4942
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
M. Kovacsovics-Bankowski (1993)



This paper is referenced by
10.5604/17322693.1177169
Medical applications of nanotechnology.
Z. Zdrojewicz (2015)
' S PROOF Metadata of the article that will be visualized in OnlineFirst 1 Article Title Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine
S. Abdrabbo (2008)
10.1080/14760584.2017.1382357
Enhancing tumor specific immune responses by transcutaneous vaccination
Hanadi Saliba (2017)
10.1038/s41598-018-35675-y
Design Optimization of Tumor Vasculature-Bound Nanoparticles
Ibrahim M Chamseddine (2018)
Statusandfutureprospectsof lipid-basedparticulatedelivery systemsasvaccineadjuvants andtheircombinationwith immunostimulators
Pernille Nordly (2009)
10.4155/TDE.11.68
Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.
C. Foged (2011)
10.1016/j.jconrel.2011.10.017
Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo.
Julio H.K. Rozenfeld (2012)
Induces Discrete Immunological Imprints Microparticles by Pulmonary APC Subsets Differential Uptake of Nanoparticles and
Robyn E O'hehir (2013)
10.1021/bm4011563
Cationic dendron-bearing lipids: investigating structure-activity relationships for small interfering RNA delivery.
Yu Zhang (2013)
10.1016/B978-0-444-62614-1.00019-3
Colloidal drug delivery system for brain-targeting therapy
Yung-Chih Kuo (2014)
10.1007/s11095-007-9459-1
Multifunctional Nanoparticulate Polyelectrolyte Complexes
Sean M. Hartig (2007)
10.1016/j.steroids.2017.09.007
Attenuation of antimicrobial activity by the human steroid hormones
Balbina J Plotkin (2017)
10.1002/ange.202002979
Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells
Hyojung Park (2020)
10.1016/j.biomaterials.2010.07.067
The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility.
B. Dash (2010)
Engineering tolerance using biomaterials to target and control antigen presenting cells.
Lisa H. Tostanoski (2016)
10.1021/acsnano.6b07343
Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.
K. Gause (2017)
Formulation and In Vitro Characterization of Polymeric Nanoparticles Designed for Oral Delivery of Levofloxacin Hemihydrate
Y. Yazan (2016)
10.1007/978-3-319-43525-1_14
Pharmacokinetics and Pharmacodynamics of Nano-Drug Delivery Systems
A. Maity (2016)
10.2147/ITT.S62471
Nanocarrier-based immunotherapy in cancer management and research
M. S. Singh (2014)
10.1016/j.ijpharm.2012.04.047
Vaccine delivery carriers: insights and future perspectives.
J. Correia-Pinto (2013)
10.1007/978-3-319-18045-8_11
Targeting Liposomes to Immune Cells
Matthew Levy (2015)
10.1016/B978-0-323-47720-8.00011-0
Nanovaccines for oral delivery-formulation strategies and challenges
Sayali Karandikar (2017)
10.1007/s11051-017-3902-y
Solid lipid nanoparticles mediate non-viral delivery of plasmid DNA to dendritic cells
A. Penumarthi (2017)
10.3390/nano8070454
Effects of Sample Preparation on Particle Size Distributions of Different Types of Silica in Suspensions
Rodrigo R Retamal Marín (2018)
10.1016/j.actbio.2017.08.006
Investigation of cationized triblock and diblock poly(ε-caprolactone)-co-poly(ethylene glycol) copolymers for oral delivery of enoxaparin: In vitro approach.
Pimchanok Charoongchit (2017)
10.1098/rsif.2017.0787
A model-based analysis of tissue targeting efficacy of nanoparticles
Dipak Barua (2018)
10.1016/j.ejpb.2018.11.003
Robust mucosal and systemic responses against HTLV‐1 by delivery of multi‐epitope vaccine in PLGA nanoparticles
M. Kabiri (2018)
10.1586/14787210.2013.845524
Delivery of host cell-directed therapeutics for intracellular pathogen clearance
Michael A. Collier (2013)
10.1007/s11095-012-0891-5
Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery
N. Kunda (2012)
10.1007/s13346-020-00719-2
Immune cell engineering: opportunities in lung cancer therapeutics
Arpit Bhargava (2020)
10.1080/1539445X.2014.912222
Nano-Size Effect of Hyperbranched Polyglycerol-Grafted Fe3O4 Nanoparticles
L. Wang (2014)
10.1016/j.ijpharm.2011.10.034
Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression.
Kevin J. Kauffman (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar